Cardinal Health (CAH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
21 Sep, 2026Executive summary
Annual meeting scheduled for November 12, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by November 11, 2026, or November 6, 2026, for shares held in a plan.
Voting matters and shareholder proposals
Election of eleven directors is on the agenda, with all nominees recommended by the board.
Advisory vote on executive compensation (say-on-pay) is included.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending June 30, 2027.
Other business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Eleven director nominees are listed for election, including both independent and executive members.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Cardinal Health
- Double-digit growth across all segments, with specialty and acquisitions driving future strategy.CAH
2026 Global Healthcare Conference - Strong financial results, board refreshment, and enhanced risk oversight mark fiscal 2026.CAH
Proxy filing - Guidance targets 13%-15% EPS growth in 2027, led by specialty and pharma investments.CAH
Morgan Stanley 24th Annual Global Healthcare Conference - Specialty and generics growth, strategic M&A, and disciplined investment drive strong outlook.CAH
Wells Fargo 21st Annual Healthcare Conference - Strong FY26 results, double-digit profit growth, and robust FY27 EPS guidance.CAH
Q4 2026 - Double-digit growth, innovation, and disciplined investment drive a strong outlook for the year.CAH
Evercore ISI 8th Annual HealthCONx Conference - Profit growth, raised guidance, and strategic M&A drive momentum and long-term resilience.CAH
Bank of America Global Healthcare Conference 2026 - Specialty and diversified segments drive robust growth, with $10B+ cash flow expected.CAH
Baird Global Healthcare Conference 2025 - Record FY24 results and raised FY25 guidance signal strong profit growth ahead.CAH
Q4 2024